Spanish Red Biotech Pipeline

Novo Nordisk Pharma

Oral semaglutide

Type: Biodrugs/ Drugs
Therapeutic area: Metabolic / Endocrinology
Indication: Diabetes type 2
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I